Indiana Attorney General Todd Rokita is accusing Eli Lilly of conspiring with its competitors to artifically raise the price ...

Eli Lilly has the lead in the GLP-1 race, but Novo Nordisk just changed the game.

Eli Lilly (LLY) is back in focus after recent trading put its market performance under the microscope, as investors weigh its ...

The lawsuit alleges insulin can cost Eli Lilly just a few dollars to produce, while some consumers are charged hundreds of ...

Attorney General Todd Rokita is intensifying his efforts to lower insulin prices and improve healthcare affordability for ...

Eli Lilly has quietly turned a blockbuster obesity and diabetes franchise into one of the market's most intriguing income ...

The fierce rivalry between Novo Nordisk and Eli Lilly is alive and well, as the two companies are expected to face off with ...

Indiana Attorney General Todd Rokita sues Eli Lilly, accusing them of inflating insulin prices by over 1000% despite low manufacturing costs.

Indiana Attorney General Todd Rokita has filed a lawsuit against Eli Lilly and Company, alleging that the drugmaker has ...

This year's Rose Bowl was so uncompetitive that fans paid more attention to the commercials than the actual game. To be fair, ...

Attorney General Todd Rokita said the lawsuit, filed last Wednesday in the Lake County Superior Court, is part of his ...

Rokita says Eli Lilly was part of a scheme that inflated insulin prices over the past decade by more than 1000%, despite low ...